1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal CancerHedgehog Inhibitor; PARP Inhibitor; Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Primary Peritoneal CarcinomaRecruitingPhase 22026-06-18NCT05538091